Since all cannabinoids are Schedule I drugs in the US and Schedule II in Canada, you have to jump through a bunch of hoops and red tape to get your hands on it for research.
Research is emerging and more comprehensive studies are needed, but science is getting there. Here’s just a smattering of the things scientists were able to demonstrate that CBD does:
Measurably relieved chronic pain in combination with THC[2][3][4]
Triggered breast cancer cell death[5] and down-regulated the gene that makes certain aggressive strains of breast cancer proliferate[6]
Inhibited lung cancer invasion and metastasis (spread)[7]
Significantly reduced multiple sclerosis symptoms in patients in a randomized, placebo-controlled study[8] and a larger series of multi-center randomized placebo-controlled trials[9]
In larger doses (160mg), it helped participants you sleep — even in people who typically suffer from insomnia.[10]
Higher doses decreased anxiety during public speaking.[11]
Increased alertness in small doses (15 mg) in humans and rats.[12][13]
Decreased social anxiety by regulating the amygdala, a part of your brain that controls fear.[17]
Substantially improved symptoms of schizophrenia.[18]
Showed antioxidant activity. A test tube study showed that CBD protected neurons from inflammation and oxidative stress better than both vitamin C and vitamin E,[19] and it prevented oxidative damage to DNA associated with colon cancer.[20]
Showed potential as a neuroprotective. CBD decreased brain damage after stroke in rats.[21]
There’s more — anxiety, neurodegenerative diseases, autoimmune conditions — CBD is worth a look in any disease process that’s rooted in inflammation (which is most of them).
Source & Learn more here: https://blog.bulletproof.com/cbd-oil-benefits-effects/